Search company, investor...

Shuangcheng Pharmaceuticals

shuangchengmed.com

Stage

IPO | IPO

Total Raised

$12.92M

Date of IPO

8/8/2012

About Shuangcheng Pharmaceuticals

Shuangcheng Pharmaceuticals engages in the development, manufacture, and marketing of both active pharmaceutical ingredients (APIs) and finished drug products.

Headquarters Location

16 Xingguo Road Xiuying District

Haikou, Hainan, 570314,

China

86 898 68592978

Missing: Shuangcheng Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Shuangcheng Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Shuangcheng Pharmaceuticals Frequently Asked Questions (FAQ)

  • Where is Shuangcheng Pharmaceuticals's headquarters?

    Shuangcheng Pharmaceuticals's headquarters is located at 16 Xingguo Road, Haikou.

  • What is Shuangcheng Pharmaceuticals's latest funding round?

    Shuangcheng Pharmaceuticals's latest funding round is IPO.

  • How much did Shuangcheng Pharmaceuticals raise?

    Shuangcheng Pharmaceuticals raised a total of $12.92M.

  • Who are the investors of Shuangcheng Pharmaceuticals?

    Investors of Shuangcheng Pharmaceuticals include SEAVI Advent, IDG-Accel, Cowin Capital and Zhejiang Silicon Paradise Asset Management Group.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.